On November 13, 2016, The Third Meeting of 10^th PhIRDA General Assembly elected new leadership of the association:

Annual Chairman:

2016-2017 Annual Chairman:

Ding Lieming, Chairman of the Board, Beta Pharmaceutical Co., Ltd.

2017-2018 Annual Chairman Candidate:

Jiang Jiandong, Director, Institute of Materia Medica, Chinese Academy of Medical Sciences

Executive President:

Song Ruilin, Executive President, China Pharmaceutical Innovation and Research Development Association

Vice-Presidents:

Chen Qiyu, Chairman of the Board, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Yan Xijun, Chairman of the Board, Tasly Holding Group

Sun Piaoyang, Chairman of the Board, Jiangsu Hengrui Medicine Co., Ltd.

Jiang Hualiang, Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Jiang Jiandong, Director, Institute of Materia Medica, Chinese Academy of Medical Sciences

Zhang Boli, President, Tianjin University of Traditional Chinese Medicine, Academician，Chinese Academy of Engineering

Cai Dongchen, Chairman of the Board, CSPC hldings company limited Co., Ltd.

Ren Jinsheng, Chairman of the Board, Simcere Pharmaceutical Group

Shi Shengyi, Deputy General Manager of Sinopharm Group Corporation, Chairman of the Board of China Sinopharm International Corporation

Shu Chang, Vice President, Shanghai Pharmaceuticals Holding Co., Ltd.

Ke Zunhong, Chairman of the Board, Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Liu Dianbo, Chairman of the Board, LUYE Pharma Group Co., Ltd.

Secretary-General:

Feng Lan, Secretary-General, China Pharmaceutical Innovation and Research Development Association